Wolfgang Heldt

Title: Wolfgang Heldt: Innovator in Sulfoximide Derivatives

Introduction

Wolfgang Heldt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of chemistry, particularly in the development of certain heterocyclic sulfoximide derivatives. His work has implications in the pharmaceutical industry, showcasing the potential for innovative treatments.

Latest Patents

Wolfgang Heldt holds a patent for "Certain heterocyclic sulfoximide derivatives." This patent describes compounds of the general formula wherein R1 is a phenyl, thienyl, furyl, or pyridyl ring; R2 is a thienyl, furyl, or pyridyl ring; R3 and R4 are the same or different and are alkyl groups containing up to 6 carbon atoms or together with the nitrogen atom to which they are attached form a pyrrolidine, piperidine, or morpholine ring; and n is a whole number from 1 to 5. The compounds exhibit anti-bronchospasmolytic activity, highlighting their potential therapeutic benefits.

Career Highlights

Throughout his career, Wolfgang Heldt has focused on innovative chemical compounds that can lead to advancements in medical treatments. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Wolfgang has collaborated with esteemed colleagues such as Peter Stoss and Gerhard Satzinger. These partnerships have fostered an environment of innovation and have contributed to the success of his research endeavors.

Conclusion

Wolfgang Heldt's contributions to the field of sulfoximide derivatives exemplify the impact of innovative research in chemistry. His work not only advances scientific knowledge but also holds promise for future pharmaceutical applications.